Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded Non catigories Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded AETOSWire sarjatha 3 November، 2022 London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update...Read More
